The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: A subgroup analysis of TRENDS
Abstract
Background The temporal relationship between atrial tachyarrhythmias (atrial tachycardia [AT] and atrial fibrillation [AF]) and cerebrovascular events/systemic emboli (CVE/SE) is unknown.Objective The purpose of this study was to evaluate this relationship using stored AT/AF diagnostic data from implanted devices in patients with and those without AF.Methods The TRENDS study enrolled 2,486 patients with an indication for an implantable device, at least one stroke risk factor, and available device data. The current study includes the subgroup of 40 (1.6%) patients enrolled in TRENDS who experienced CVE/SE.Results AT/AF was detected prior to CVE/SE in 20 (50%) of 40 patients. Other than average and maximum daily AT/AF burden and duration of device monitoring prior to CVE/SE, no statistically significant differences were found between patients with and those without AT/AF prior to CVE/SE. For the 20 patients with AT/AF detected prior to CVE/SE, 9 (45%) did not have any AT/AF in the 30 days prior to CVE/SE. Therefore, 29 (73%) of 40 patients with CVE/SE had zero AT/AF burden within 30 days prior to CVE/SE. Fourteen (70%) of the 20 patients with AT/AF detected prior to CVE/SE were not in AT/AF at diagnosis of CVE/SE. The last episode of AT/AF in these 14 patients was 168 ± 199 days (range 3-642 days) before CVE/SE.Conclusion The majority of CVE/SE in this population did not occur proximal to recent AT/AF episodes. These data imply that the mechanisms of CVE/SE in patients with implantable devices may importantly involve mechanisms other than cardioembolism due to atrial tachyarrhythmias.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Strokes often occur without AHRE detected within 30 days before the event.143-147”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [146]
Citations
Cites
Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010) · Chest · doi:10.1378/chest.09-1584 · Cited by 6,879
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
A comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
Calkins, H. G., Brugada, J., Packer, D. L., Cappato, R., Chen, S., Crijns, H. J. G. M., Damiano, R. J., Davies, D. W., Haines, D. E., Haı̈ssaguerre, M., et al. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2007.04.005 · Cited by 1,690
Calkins, H. G., Brugada, J., Packer, D. L., Cappato, R., Chen, S.-A., Crijns, H. J. G. M., Damiano, R. J., Davies, D. W., Haines, D. E., Haïssaguerre, M., et al. (2007) · EP Europace · doi:10.1093/europace/eum120 · Cited by 1,289
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
Watson, T., Shantsila, E., & Lip, G. Y. H. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60040-4 · Cited by 1,124
Marini, C., De Santis, F., Sacco, S., Russo, T., Olivieri, L., Totaro, R., & Carolei, A. (2005) · Stroke · doi:10.1161/01.str.0000166053.83476.4a · Cited by 949
Glotzer, T. V., Daoud, E. G., Wyse, D. G., Singer, D. E., Ezekowitz, M. D., Hilker, C., Miller, C., Qi, D., & Ziegler, P. D. (2009) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.109.849638 · Cited by 879 · cited 2×
“5 hours in any 30-day period doubled CVE/SE risk.(7) However, in the current study, patient-specific analysis revealed that only 50% of patients who experienced CVE/SE had any episode of AT/AF prior to the CVE/SE.”
BackgroundAnticoagulation Therapy for Stroke Prevention in Atrial Fibrillation
Go, A. S., Hylek, E. M., Chang, Y., Phillips, K. A., Henault, L. E., Capra, A. M., Jensvold, N. G., Selby, J. V., & Singer, D. E. (2003) · JAMA · doi:10.1001/jama.290.20.2685 · Cited by 705
The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study
Olshansky, B., Rosenfeld, L. E., Warner, A. L., Solomon, A. J., O’Neill, G., Sharma, A. D., Platia, E. V., Feld, G. K., Akiyama, T., Brodsky, M. A., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.11.032 · Cited by 599
The Stroke Prevention in Atrial Fibrillation Investigators (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-1-6 · Cited by 546
Adams, R. J., Albers, G. W., Alberts, M. J., Benavente, O., Furie, K. L., Goldstein, L. B., Gorelick, P. B., Halperin, J. L., Harbaugh, R. E., Johnston, S. C., et al. (2008) · Stroke · doi:10.1161/strokeaha.107.189063 · Cited by 478
Pollick, C., & Taylor, D. (1991) · Circulation · doi:10.1161/01.cir.84.1.223 · Cited by 477
Waldo, A. L., Becker, R. C., Tapson, V. F., & Colgan, K. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.06.077 · Cited by 378
Sherman, D. G. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.10.1185 · Cited by 232
Patients With Atrial Fibrillation and Dense Spontaneous Echo Contrast at High Risk
Bernhardt, P., Schmidt, H., Hammerstingl, C., Lüderitz, B., & Omran, H. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.11.071 · Cited by 183
Accuracy of Atrial Tachyarrhythmia Detection in Implantable Devices with Arrhythmia Therapies
Pürerfellner, H., Gillis, A. M., Holbrook, R., & Hettrick, D. A. (2004) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2004.00569.x · Cited by 162
POLLAK, W. M., SIMMONS, J. D., Interian, A., Atapattu, S. A., Castellanos, A., Myerburg, R. J., & Mitrani, R. D. (2001) · Pacing and Clinical Electrophysiology · doi:10.1046/j.1460-9592.2001.00424.x · Cited by 155
Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation
Nakano, Y., Niida, S., Dote, K., Takenaka, S., Hirao, H., Miura, F., Ishida, M., Shingu, T., Sueda, T., Yoshizumi, M., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.08.060 · Cited by 153
Cryptogenic Stroke and underlying Atrial Fibrillation (CRYSTAL AF): Design and rationale
Sinha, A. M., Diener, H., Morillo, C. A., Sanna, T., Bernstein, R. A., Lazzaro, V. D., PASSMAN, R. S., Beckers, F., & Brachmann, J. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.03.032 · Cited by 134
Marín, F. R., Roldán, V., Climent, V. E., Garcı́a, A., Marco, P., & Lip, G. Y. H. (2003) · Stroke · doi:10.1161/01.str.0000065431.76788.d9 · Cited by 99
Inoue, H., Nozawa, T., Okumura, K., Jong-Dae, L., Shimizu, A., & Yano, K. (2004) · CHEST Journal · doi:10.1378/chest.126.3.687 · Cited by 77
Current Status of Stroke Risk Stratification in Patients With Atrial Fibrillation
Hart, R. G., & Pearce, L. A. (2009) · Stroke · doi:10.1161/strokeaha.109.549428 · Cited by 74
Assessment of Left Atrial Appendage Structure and Function by Transesophageal Echocardiography
Yao, S., Meisner, J. S., Factor, S. M., Frank, C. W., Strom, J. A., & Shirani, J. (1998) · Echocardiography · doi:10.1111/j.1540-8175.1998.tb00603.x · Cited by 73
Left Atrial Appendage Occlusion Does Not Eliminate the Need for Warfarin
Whitlock, R. P., Healey, J. S., & Connolly, S. J. (2009) · Circulation · doi:10.1161/circulationaha.108.844779 · Cited by 65
Glotzer, T. V., Daoud, E. G., Wyse, D. G., Singer, D. E., Holbrook, R., Pruett, K., Smith, K., & Hilker, C. E. (2006) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-006-7622-y · Cited by 40
Turgut, N., Akdemir, O., Turgut, B., Demir, M., Ekuklu, G., Vural, Ö., Özbay, G., & Utku, U. (2006) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/107602960601200104 · Cited by 37
Sung, S., Chang, S., HSU, T., YU, W., TAI, C., Lin, Y., Lo, L., Wongcharoen, W., Tuan, T., Hu, Y., et al. (2007) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2007.00982.x · Cited by 31
Tamura, H., Watanabe, T., Hirono, O., Nishiyama, S., Sasaki, S., Shishido, T., Miyashita, T., Miyamoto, T., Nitobe, J., Kayama, T., et al. (2010) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2010.02.006 · Cited by 30
The prothrombotic risk of diabetes mellitus in atrial fibrillation and heart failure
Varughese, G. I., Patel, J. V., Tomson, J., & Lip, G. Y. H. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01694.x · Cited by 29
Stroke Prevention in Atrial Fibrillation and Other Major Cardiac Sources of Embolism
Freeman, W. D., & Aguilar, M. I. (2008) · Neurologic Clinics · doi:10.1016/j.ncl.2008.07.001 · Cited by 29
Atrial Fibrillation: Goals of Therapy and Management Strategies to Achieve the Goals
Padanilam, B. J., & Prystowsky, E. N. (2008) · Cardiology Clinics · doi:10.1016/j.ccl.2008.09.006 · Cited by 19
Flagged first, then by citations
Cited by
Sorted by citations
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,438
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
Calkins, H. G., Hindricks, G., Cappato, R., Kim, Y., Saad, E., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, A. J., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.05.012 · Cited by 2,794
Calkins, H., Kuck, K. H., Cappato, R., Brugada, J., Camm, A. J., Chen, S.-A., Crijns, H. J. G., Damiano, R. J., Davies, D. W., DiMarco, J., et al. (2012) · Europace · doi:10.1093/europace/eus027 · Cited by 2,722
Calkins, H. G., Kück, K., Cappato, R., Brugada, J., Camm, A. J., Chen, S., Crijns, H. J. G. M., Damiano, R. J., Davies, D. W., Dimarco, J., et al. (2012) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-012-9672-7 · Cited by 1,685
Metadata
- Authors
- Daoud, E. G., Glotzer, T. V., Wyse, D. G., Ezekowitz, M. D., Hilker, C., Koehler, J., & Ziegler, P. D.
- Affiliations
- The Ohio State University Wexner Medical Center (US)
- Hackensack University Medical Center (US)
- Libin Cardiovascular Institute of Alberta (CA)
- Lankenau Institute for Medical Research (US)
- Medtronic (United States) (US)
- Corresponding author
- Daoud, Emile G.
- Venue
- Heart Rhythm
- Publisher
- Elsevier BV
- Published
- 2011-09
- Volume
- 8
- Issue
- 9
- Pages
- 1416-1423
- ISSN
- 1547-5271 (ISSN-L)
- OpenAlex
- W2020006237
- Cited by
- 326
- References
- 33
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 20 · 2023: 18 · 2022: 20 · 2021: 28 · 2020: 20 · 2019: 19 · 2018: 31 · 2017: 38 · 2016: 39 · 2015: 26 · 2014: 24 · 2013: 10 · 2012: 11
- FWCI
- 10.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Heart Rhythm (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medtronic
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Keywords
- atrial tachyarrhythmia, atrial fibrillation, atrial tachycardia, cerebrovascular events, systemic embolism, stroke, temporal relations, cardiac implantable electronic devices, device monitoring, cardiac embolism
- MeSH terms
- Aged, Aged, 80 and over, Atrial Fibrillation, Cardiac Pacing, Artificial, Embolism, Female, Humans, Male, Middle Aged, Product Surveillance, Postmarketing, Prospective Studies, Tachycardia, Ectopic Atrial, Information Storage and Retrieval, Defibrillators, Implantable, Brain Infarction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
